Medical costs soar for U.S. babies born addicted to opioids

June 15, 2017 by Amy Norton, Healthday Reporter

(HealthDay)—The number of U.S. newborns hospitalized for opiate withdrawal has spiked sharply in recent years—and so has the cost of treating them, a new study shows.

In fact, the national bill for caring for these fragile newborns now runs in the hundreds of millions of dollars, the study found.

Researchers have known that the U.S. epidemic of painkiller abuse is extending to infants. Recent studies have charted a steep rise in so-called neonatal abstinence syndrome (NAS), the researchers said.

Most often, newborns suffer the condition because their mother took opioid painkillers—such as OxyContin or Vicodin—during pregnancy. Babies are born dependent on the drugs and quickly develop withdrawal symptoms.

That can mean a host of problems, from tremors and seizures, to breathing difficulty, to diarrhea and poor feeding.

Last year, a federal study found that the number of U.S. infants born with NAS tripled between 1999 and 2013—at least across the 28 states that had data.

The new study, published June 14 in the journal Addiction, adds another layer: The financial toll.

By 2012, researchers found, NAS was costing the United States over $300 million in hospital care. That was up from $61 million in 2003.

And compared with other hospitalized newborns, those with NAS had stays that were three times as long and three times as costly.

"Opioid use during pregnancy comes at a cost to the baby—both in potential as well as length of hospital admission," said researcher Dr. Tammy Corr, a newborn medicine specialist at Penn State Hershey Medical Center.

Dr. Nicole Villapiano is a pediatrician at the University of Michigan's C.S. Mott Children's Hospital.

In a recent study, she found that NAS is hitting especially hard. Between 2003 and 2012, cases in rural areas rose from 1.2 per 1,000 births to 7.5 per 1,000. In contrast, the rate in U.S. cities rose from 1.4 cases for every 1,000 births to 4.8 per 1,000.

That disparity is no surprise, according to Villapiano, since rural communities are at the center of the opioid epidemic.

The new study may actually underestimate the costs of NAS, Villapiano said, because it could not account for newborns at small community hospitals who had to be transferred to urban medical centers.

That points to a bigger issue, according to Villapiano. Rural hospitals are not necessarily equipped to handle NAS, and women who live in those areas, pregnant or not, may not have access to help for opioid addiction.

Quitting opioids "cold turkey," even if possible, is dangerous, Villapiano said. The recommended treatment for dependence is medication, like methadone or buprenorphine, along with behavioral counseling.

But that can be hard to come by in , she added.

"And finding a facility that will deliver that care to a pregnant woman is very challenging," Villapiano said.

Corr agreed that addicted to opioids can face tough barriers.

"State policies vary in their treatment of pregnant women who have a substance abuse problem," Corr said. Those policies, she noted, range from offering women help with treatment, to "criminalization."

"Rather than treating as a crime—which may discourage expectant mothers from seeking help—we need drug treatment programs that are specifically targeted to pregnant women," Corr said.

The findings are based on pediatric discharge records from more than 4,000 U.S. hospitals. Between 2003 and 2012, Corr's team found, hospital admissions for NAS rose more than fourfold.

Those babies ended up with longer hospital stays than newborns hospitalized for other reasons—almost 17 days, on average, versus five days. And the typical cost approached $17,000, versus $5,600.

Babies with NAS do seem to recover well, Villapiano said—though it's not clear whether some might have lingering issues with attention or other behavior later on.

Ideally, both researchers said, prenatal exposure to opioids should be prevented in the first place.

Women who are abusing opioids—or taking a legitimate prescription—should be aware of the risks of using the drugs during pregnancy, Corr said.

"If a woman does become pregnant while using opioids," she added, "she should notify her provider immediately to seek the appropriate help—to provide the best outcomes for herself and her baby."

Explore further: Study: Rural communities see steep increase in babies born with opioid withdrawal

More information: Tammy Corr, D.O., assistant professor, pediatrics, division of newborn medicine, Penn State Hershey Medical Center, Hershey, Pa.; Nicole Villapiano, M.D., pediatrician, University of Michigan's C.S. Mott Children's Hospital, Ann Arbor; June 14, 2017, Addiction

The March of Dimes has more on neonatal abstinence syndrome.

Related Stories

Study: Rural communities see steep increase in babies born with opioid withdrawal

December 12, 2016
The number of babies born with drug withdrawal symptoms from opioids grew substantially faster in rural communities than in cities, a new study suggests.

NIH-led workshop addresses opioid misuse during pregnancy

June 9, 2017
Research is essential to determining how best to screen pregnant women for opioid use disorder, to treat pregnant women who have the disorder, and to care for infants as they experience withdrawal symptoms, according to experts ...

The cost of opioid use during pregnancy

June 14, 2017
A new study published today by the scientific journal Addiction reveals that the incidence of neonatal abstinence syndrome - often caused by mothers using opioids during pregnancy - is increasing in the United States, and ...

Steep rise in births to U.S. women using opioids

January 17, 2017
(HealthDay)—Over a decade, there was a nearly fivefold increase in the number of babies born each year to American women who have used opioids, a federal government report says.

Buprenorphine found superior to Methadone in treating infants born in drug withdrawal

January 6, 2016
A study of two opioids used to wean babies born in withdrawal from drugs their mothers have taken shows that buprenorphine is superior to methadone in reducing duration of treatment and length of hospital stay.

Don't punish pregnant women for opioid use, docs say

February 20, 2017
(HealthDay)—Prevention and treatment, not legal action, should be the focus when dealing with pregnant women who use opioids, a leading pediatricians' group says.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.